• Home
    • Medication Information Library
    • Medication Interactions
    • Medication Identifier
  • Comments
  • Posts
meds watch
CHEST
  • Home
  • Meds-Watch Home
  • Medication Information Library
  • Medication Interactions
  • Medication Identifier
The Medical Letter Online

Human medicines European Public Assessment Report (EPAR): Tasigna, nilotinib, Revision: 16, Authorised

admin | June 20, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Tags: assessment, Authorised, EPAR, European, human, medicines, nilotinib, Public, report, Revision, Tasigna

Category: European Medicines Agency

Subscribe

If you enjoyed this article, subscribe to receive more just like it.

Subscribe via RSS Feed

Leave a Reply

Click here to cancel reply.

« Euphoria Fancy Food Inc Issues an Alert on Uneviscerated Fish
Vismodegib »

Archives

  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
Poison Help

RSS ASHP – Current Drug Product Shortages

  • Meropenem Injection Some May 22, 2013
    Drug: Meropenem, Revision Date: Wed, 22 May 2013 […]
  • Phenytoin Injection Some May 22, 2013
    Drug: Phenytoin Injection, Revision Date: Wed, 22 May 2013 […]
  • Esmolol Injection Some May 22, 2013
    Drug: Esmolol, Revision Date: Wed, 22 May 2013 […]
  • Orphenadrine Citrate Injection Some May 22, 2013
    Drug: Orphenadrine, Revision Date: Wed, 22 May 2013 […]

RSS ASHP – Resolved Drug Shortages

  • Cefaclor Suspension Some May 15, 2013
    Drug: Cefaclor, Revision Date: Wed, 15 May 2013 […]
  • Foscarnet Injection May 10, 2013
    Drug: Foscarnet, Revision Date: Fri, 10 May 2013 […]
  • Mepivacaine Injection May 9, 2013
    Drug: Mepivacaine, Revision Date: Thu, 09 May 2013 […]
  • Amobarbital Injection All May 6, 2013
    Drug: Amobarbital, Revision Date: Mon, 06 May 2013 […]

RSS ASHP – Drug Products No Longer Available

  • Japanese Encephalitis Virus Inactivated Vaccine May 22, 2013
    Drug: Japanese Encephalitis Virus Inactivated Vaccine, Revision Date: Wed, 22 May 2013 […]
  • Ganciclovir Capsules None May 15, 2013
    Drug: Ganciclovir Capsules, Revision Date: Wed, 15 May 2013 […]
  • Mesalamine 400 mg Delayed-Release Tablet (Asacol) April 5, 2013
    Drug: Mesalamine, Revision Date: Fri, 05 Apr 2013 […]
  • Sotalol Injection None March 26, 2013
    Drug: Sotalol, Revision Date: Tue, 26 Mar 2013 […]

Categories

  • European Medicines Agency
  • FDA Drug Info Rounds
  • FDA Drug Shortages
  • Health Canada
  • Latest Medication News
  • MedEffect Canada
  • Medications
  • MedWatch Safety Alerts
  • Nature reviews-Drug Discovery
  • Recalls
  • What's New: Drugs

RSS Latest Medication News

  • Trial watch: PDE4 inhibitor leads wave of target-specific oral psoriasis drugs April 30, 2013 Charlotte Harrison
  • Translational medicine: mitigating risks for investigators April 30, 2013 Douglas L. Mann
  • Mini-Sentinel saves dabigatran April 30, 2013
  • Maturing antibody–drug conjugate pipeline hits 30 April 30, 2013 Asher Mullard
  • Big expectations for Biogen's small MS drug April 30, 2013
  • FDA issues Alzheimer's rethink April 30, 2013
  • Trial watch: Sepsis study failure highlights need for trial design rethink April 30, 2013 Man Tsuey Tse
  • Tumour vaccination: Devil in the details of adjuvant choice April 30, 2013 Alexandra Flemming
  • Platforms for antibiotic discovery April 30, 2013 Kim Lewis
  • In this issue April 30, 2013

Recent Posts

  • Test Your Home for Radon During Lung Cancer Awareness Month
  • News and press releases: European Medicines Agency website unavailable intermittently Saturday 6 October
  • Ameridose Issues Recall of All Products
  • Classic Zi Xiu Tang Bee Pollen Capsules And Ultimate Formula Capsules by Zi Xiu Tang Success: Recall – Undeclared Sibutramine
  • Metabolic disorders: Safe cannabinoid receptor modulators in sight?

Tags

2012 adopted Agency Alert Allergy assessment Authorised Because Class Communication Current Decision Draft Drug Drugs EPAR European Final From Health human Inc. Injection Issues medicines News Notice Possible Potential Press Product Products Public Recall Recalls Releases report Revision Risk Safety Shortages Solution Undeclared updated Voluntary

meds watch

© 2013 meds watch. All rights reserved. Premium WordPress Themes.